Transplantation Market (By Product: Tissue Products, Immunosuppressive Drugs, Preservation Solution; By Application: Organ, Tissue Transplant; By End Use: Hospitals, Transplant Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 20222030

The global transplantation market size was valued at USD 12.5 billion in 2021 and is expected to surpass around USD 31 billion by 2030 with a CAGR of 9.4% from 2022 to 2030. Growing incidence of organ failure has resulted in massive growth in the transplantation market.

Rising demand for transplant products such as tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market’s growth during the forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for the management of organ failure.

Technological advancement in organ transplantation methods is another major factor supporting the market growth. The development of novel & improved transplant products such as tissue products and surgical instruments has majorly contributed to the expansion of the sector.

In addition, the introduction of advanced tissue products such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment.  In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, the availability of such advanced techniques supports an increase in the number of organ transplant procedures.

Scope of the Transplantation Market

Report Coverage Details
Market Size by 2030 USD 31 billion
Growth Rate from 2022 to 2030 CAGR of 9.4%
Base Year 2021
Forecast Data 2022 to 2030
Segmentation Profuct, Application, End User, Region

Product Insight

Tissue products were the highest revenue-generating segment in 2021 with a market share of 57.8%. Major products used for tissue or organ transplantation are tissue products, immunosuppressants, and preservation solutions. The increasing number of transplantation procedures such as that of cochlear, heart valves, bone marrow, and orthopedic soft tissues is attributed to the growth of the segment. In addition, new product development is also fueling market growth.

The preservation solutions segment is expected to exhibit significant growth during the study period due to rising government support for stem cell research and the high application of these products to improve the physiological function of organs. In addition, rising cases of organ failure, increasing organ transplant procedures, and escalating number of organ donations worldwide are expected to drive the segment growth.

Application Insight

Tissue transplantation dominates the market with market size of 7.6 billion in 2021. This is due to the fact that the replacement of skin, cornea, bones, heart valves, tendons, nerves, and veins are most commonly performed procedure worldwide. The escalating number of burn and accident cases is expected to propel the demand for tissue products.

The organ transplantation segment is expected to show a lucrative growth rate during the forecast period. The increasing number of organ transplantations globally as well as the repetitive purchase of immunosuppressants is anticipated to boost the market growth in the near future. For instance, in 2017, around 90,306 kidney transplant procedures were performed globally.

End-Use Insight

The hospitals segment held the largest market share of 49.6% in the year 2021. A large number of organ and tissue transplant procedures are conducted at hospitals as they are primary treatment centers. Additionally, the emergence of hospitals with developed infrastructure is further expected to fuel market growth.

The number of transplant centers is expected to exhibit the highest growth during the forecast period. Escalating transplantation procedures have triggered the need for an increased number of healthcare centers catering to the unmet needs of the patients. Also, rising government initiatives to encourage organ donation are projected to propel market growth.

Regional Insights

In 2021, North America dominated the transplantation market with a market share of 39.4% and is expected to maintain its dominance throughout the study period. Well-developed healthcare facilities and the local presence of many large biotechnology and medical devices companies, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker are supporting the market growth.

Asia Pacific market is projected to rise at the highest rate during the forecast period, owing to the growing research on stem cells to develop in-vitro tissue and organs as well as developing healthcare infrastructure in Asian countries such as India, Thailand, Philippines, Indonesia.

Key Players

  • Stryker Corp.

  • Medtronic PLC

  • AbbVie Inc.

  • Zimmer Biomet

  • Novartis International AG

  • 21st Century Medicine

  • Biolife Solutions

  • Teva Pharmaceutical

  • Veloxis Pharmaceuticals

Market Segmentation

  • Product Type Outlook 

    • Tissue Products

    • Immunosuppressive Drugs

    • Preservation Solutions

  • Application Type Outlook 

    • Organ Transplant

    • Tissue Transplant

  • End-use Outlook 

    • Hospitals

    • Transplant Centers

    • Others

  • Regional Outlook 

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2021) and forecast (2022-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Transplantation Market, By Product

7.1.  Transplantation Market, by Product Type, 2020-2030

7.1.1.    Tissue Products

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Immunosuppressive Drugs

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Preservation Solutions

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Transplantation Market, By Application

8.1.  Transplantation Market, by Application, 2020-2030

8.1.1.    Organ Transplant

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Tissue Transplant

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Transplantation Market, By End-use

9.1.  Transplantation Market, By End-use, 2020-2030

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Transplant Centers

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Others

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Transplantation Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Product (2016-2030)

10.1.2.  Market Revenue and Forecast, by Application (2016-2030)

10.1.3.  Market Revenue and Forecast, By End-use (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.1.4.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.1.5.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Product (2016-2030)

10.2.2.  Market Revenue and Forecast, by Application (2016-2030)

10.2.3.  Market Revenue and Forecast, By End-use (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.4.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.5.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.6.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.7.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Product (2016-2030)

10.3.2.  Market Revenue and Forecast, by Application (2016-2030)

10.3.3.  Market Revenue and Forecast, By End-use (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.4.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.5.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.6.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.7.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Product (2016-2030)

10.4.2.  Market Revenue and Forecast, by Application (2016-2030)

10.4.3.  Market Revenue and Forecast, By End-use (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.4.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.5.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.6.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.7.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Product (2016-2030)

10.5.2.  Market Revenue and Forecast, by Application (2016-2030)

10.5.3.  Market Revenue and Forecast, By End-use (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.5.4.3.      Market Revenue and Forecast, By End-use (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.5.5.3.      Market Revenue and Forecast, By End-use (2016-2030)

Chapter 11.  Company Profiles

11.1.              Stryker Corp.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Medtronic PLC

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              AbbVie Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Zimmer Biomet

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Novartis International AG

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              21st Century Medicine

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Biolife Solutions

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Teva Pharmaceutical

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Veloxis Pharmaceuticals

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers